Piriformis Syndrome Market size was valued at US$ 246.59 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 6.0% through 2023 to 2029, reaching nearly US$ 370.79 Mn.
Piriformis Syndrome Market Overview:
The competitive landscape of the Piriformis Syndrome Market includes information about competitors. The contents include a corporate overview, financials, revenue generated, market potential, investment in research and development, new market efforts, geographical presence, firm strengths and weaknesses, product introduction, and application dominance. The preceding data points are solely relevant to the businesses' focus on the Piriformis Syndrome market.
For detail insights on this market, request for methodology here
@ https://www.maximizemarketresearch.com/request-sample/70140
Piriformis Syndrome Market Scope:
This Piriformis Syndrome market report discusses new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, opportunities in terms of emerging revenue streams, changes in market regulations, strategic market growth analysis, market size, segmented market growth, application niches, and dominance, product approvals, product launches, geographic expansion For more information on the Piriformis Syndrome market, please contact Maximize Market Research for an Analyst Brief; our experts will assist you in making an informed market choice to achieve market growth.
Piriformis Syndrome Market Segmentation:
by Cause
• Trauma
• Spasms
• Overuse injury
• Others
The market is divided into Trauma, Spasms, Overuse Injury, and Others based on the Cause. The trauma segment is anticipated to expand quickly between 2023 and 2029, with a CAGR of%. About half of individuals with piriformis syndrome have a history of trauma, either a direct buttock contusion or a hip/lower back torsional injury. The treating physician needs to have a strong index of suspicion because the remaining 50% of cases had spontaneous onsets.During the projected period of 2023-2029, the sector for spasms is anticipated to expand quickly at a CAGR of%. A spasm is an abrupt, uncontrollable contraction of a single muscle, a group of muscles, or a hollow organ like the bladder.
by Diagnostic Test
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• X-rays
• Neurophysiologic Testing
• Electromyography (EMG)
• Beatty Test
• FAIR (Flexion, adduction, and Internal Rotation) Test
• Others
by Treatment
• Medication
• NSAIDS
• Naproxen
• Ibuprofen
• Piriformis Muscle Injection
• Botox Injection
• Steroid Injection
• Physical Therapy
• Acupuncture
• Prolotherapy
• Osteopathic Manipulative Treatment (OMT)
• Surgery
• Others
The market is divided into Medication, NSAIDS, Naproxen, Ibuprofen, Piriformis Muscle Injection, Botox Injection, Steroid Injection, Physical Therapy, Acupuncture, Prolotherapy, Osteopathic Manipulative Treatment (OMT), Surgery, and Others based on the type of treatment being provided. The medication segment is anticipated to expand quickly between 2023 and 2029, with a CAGR of %. Ibuprofen and other over-the-counter analgesics can help lessen discomfort and swelling. In rare cases, your doctor may administer an injection directly into the piriformis muscle. With the use of a topical anaesthetic and corticosteroid, the spasm and pain can be reduced.
by Distribution Channel
• E-Commerce
• Retail Pharmacies
• Others
by End-User
• Hospitals & Clinics
• Diagnostic Centers
• Others
The market is divided into Hospitals & Clinics, Diagnostic Centres, and Others based on the End-User. By 2029, the Hospitals & Clinics segment is anticipated to command the greatest market share of%. This is because there are more people suffering with piriformis syndrome, which means that hospitals and clinics are treating more people with the condition. This is the main factor that is anticipated to fuel this market segment's expansion over the course of the forecast timeframe.
For any Queries Linked with the Report, Ask an Analyst
@ https://www.maximizemarketresearch.com/request-sample/70140
Piriformis Syndrome Market Key Players: The following are the key players of the Piriformis Syndrome market-
• Bayer AG
• Novartis AG
• AstraZeneca
• Endo Pharmaceuticals
• Teva Pharmaceuticals
• Omron Healthcare
• Sanofi S.A.
• DePuy Synthes Companies
• Miracle Stretch, LLC
• Flex Pharma, Inc.
• Nidd valley medical
• SEIRIN Corporation
• Others
For any Queries Linked with the Report, Ask an Analyst
@ https://www.maximizemarketresearch.com/market-report/global-piriformis-syndrome-market/70140/
Piriformis Syndrome Market Regional Analysis:
The geographical section of the research also includes individual market influencing variables and changes in market regulations that effect current and future market trends. Data points such as downstream and upstream value chain analysis, technology trends, porter's five forces analysis, and case studies are only a few of the indicators used to forecast market scenarios for various countries.
COVID-19 Impact Analysis on Piriformis Syndrome Market: The research also addresses the impact of COVID-19 on the Piriformis Syndrome market. The basic purpose of this study is to help the user understand the market in terms of definition, segmentation, market potential, noteworthy trends, and the issues that the industry is facing across key regions. The study provides micro and macroeconomic analysis of the total impact of COVID-19 on the Piriformis Syndrome Market. The specific analysis focuses on market share and size, which clearly demonstrates the influence that the pandemic has had and will have on the worldwide Piriformis Syndrome Market in the next years.
Key Questions Answered in the Piriformis Syndrome Market Report are:
- What will be the CAGR of the Piriformis Syndrome market during the forecast period (2021-2027)?
- Which segment emerged as the leading segment in the Piriformis Syndrome market?
- Which are the prominent players in the Piriformis Syndrome market?
- What key trends are likely to emerge in the Piriformis Syndrome market in the forecast period?
- What will be the Piriformis Syndrome market size by 2027?
- Which company held the largest share in the Piriformis Syndrome market in 2020?
About Us
Maximize Market Research provides B2B and B2C research on 12,500 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Our Address
- MAXIMIZE MARKET RESEARCH PVT. LTD.
- 3rd Floor, Navale IT Park Phase 2,
- Pune Bangalore Highway,
- Narhe,
- Pune, Maharashtra 411041, India.
- 🖂 [email protected]
- ✆ +91 9607365656
Global Piriformis Syndrome Market Research Report: By Cause (Trauma, Spasms, Others), Diagnostic Test (MRI, Others), Treatment (Medication, Physical Therapy, Others), Distribution Channel (Retail Pharmacies, Others), End-User – Global Forecast Till 2027Market HighlightsPiriformis syndrome is a rare neuromuscular condition in which the piriformis muscle, located in the buttock region, spasms and causes hip and buttock pain.
The conservative treatment for piriformis syndrome includes activity modification, the use of anti-inflammatory drugs, physical therapy, an injection of local anesthetics or corticosteroids, and botulin neurotoxin injections, among others.Major factors such as the growing occurrence of piriformis syndrome, increasing screening for neuromuscular conditions, growing success of drug treatment for the syndrome, and the growing geriatric population are expected to drive the growth of the global piriformis syndrome market.
Additionally, according to the data published by the National Center for Biotechnology Information (NCBI), in 2015, the occurrence rate of piriformis syndrome was 6% in patients with sciatica symptoms.However, the complications of the piriformis surgery and lack of awareness about the syndrome in developing countries may hamper the growth of the market during the assessment period.
Furthermore, challenges in the diagnosis of the piriformis syndrome may hamper the growth of the market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6249 Regional AnalysisThe global piriformis syndrome market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The North American region holds the major share of the global piriformis syndrome market, owing to the existing well-established healthcare system, increasing secondary lifestyle, and increasing geriatric population.
Europe is anticipated to hold the second largest position in the global piriformis market owing to the growing government support for research and development activities.
